Aptevo Therapeutics Inc. (APVO) vs IO Biotech, Inc. (IOBTQ)

Aptevo Therapeutics Inc. and IO Biotech, Inc. are both Biotechnology companies. Aptevo Therapeutics Inc. and IO Biotech, Inc. are of similar size ($3.5M and $3.4M). IO Biotech, Inc. has negative trailing earnings, so its P/E is not meaningful; Aptevo Therapeutics Inc. trades at 0.0×. Across the 8 metrics below, Aptevo Therapeutics Inc. leads on 4 and IO Biotech, Inc. on 4.

Valuation

Metric APVO IOBTQ Biotechnology median
P/E 0.00 n/m 7.88
P/S 0.17 n/m 11.47
P/B 0.37 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.15 0.74
EV/Sales 0.00 n/m 10.73
Earnings yield 86,377.14% 0.00% (28.84%)
Free cash flow yield (1,127.28%) 0.00% (23.03%)

Profitability

Metric APVO IOBTQ Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (446.89%) (240.48%) (57.72%)
Return on assets (186.29%) (136.03%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APVO IOBTQ Biotechnology median
Revenue growth (TTM) 92.94% — 5.64%
EPS growth (last fiscal year) 99.72% 26.77% —
Revenue growth, 5-year CAGR (26.64%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO IOBTQ Biotechnology median
Debt to equity 0.00 18.29 0.00
Current ratio 2.08 2.01 4.73
Net debt to EBITDA 0.83 0.63 0.96

Dividend

Metric APVO IOBTQ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric APVO IOBTQ Biotechnology median
Market cap 3.43m 3.45m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack